Artificial Intelligence in Myopic Maculopathy: A Comprehensive Review of Identification, Classification, and Monitoring Using Diverse Imaging Modalities

人工智能在近视性黄斑病变中的应用:利用多种成像方式进行识别、分类和监测的综合综述

阅读:1

Abstract

This review investigates the usefulness and effectiveness of artificial intelligence (AI) tools in the detection of myopic maculopathy lesions using traditional imaging techniques like fundus photography and optical coherence tomography (OCT). The role of machine learning (ML) and deep learning (DL) algorithms in the diagnosis, classification, and follow-up of highly myopic cases is discussed. A comprehensive analysis of articles published between 2018 and 2024 from PubMed, Science Direct-Elsevier, and Google Scholar identified 13 studies directly relevant to the topic. The majority of the studies were conducted in China and focused on patients with myopic macular degeneration and high myopia. The most popular AI algorithms included ResNet-18, ResNet-50, ResNet-101, DeepLabv3+ and DarkNet-19, Efficient Net (B0/B7), VOLO-D2, Efficient Former, ALFA-Mix+, and XGBoost. Reported statistical metrics ranged from 80% to 97.3% for accuracy, 80% to 99.8% for the area under the curve (AUC), 83.0% to 97.0% for sensitivity, 63.0% to 97.21% for specificity, and 0.8358 to 0.9880 for the kappa value. The findings reveal that AI models can play a supportive role in disease diagnosis, achieving performance metrics comparable to those of general ophthalmologists. Furthermore, the utilization of larger datasets of OCT and fundus images improves generalizability and diagnostic accuracy. The integration of multimodal imaging techniques, such as OCT, color fundus photographs, and ultra-wide field photographs, enhances diagnostic clinical value and enables more comprehensive disease monitoring.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。